$4.94
+0.64
(+14.88%)▲
13.12%
Downside
Day's Volatility :17.14%
Upside
4.63%
91.9%
Downside
52 Weeks Volatility :94.9%
Upside
36.97%
Period | Prenetics Global Limited Class A | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -28.09% | 4.9% | 0.0% |
6 Months | 18.46% | 5.8% | 0.0% |
1 Year | -34.85% | 17.8% | 0.0% |
3 Years | -96.25% | 20.1% | -20.6% |
Market Capitalization | 50.6M |
Book Value | $16.33 |
Earnings Per Share (EPS) | -4.28 |
PEG Ratio | 0.0 |
Wall Street Target Price | 9.0 |
Profit Margin | -262.11% |
Operating Margin TTM | -142.81% |
Return On Assets TTM | -10.9% |
Return On Equity TTM | -23.71% |
Revenue TTM | 23.2M |
Revenue Per Share TTM | 1.99 |
Quarterly Revenue Growth YOY | -63.800000000000004% |
Gross Profit TTM | 131.6M |
EBITDA | -41.6M |
Diluted Eps TTM | -4.28 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -3.32 |
EPS Estimate Next Year | -0.56 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | -0.93 |
What analysts predicted
Upside of 82.19%
Sell
Neutral
Buy
Prenetics Global Limited Class A is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Prenetics Global Limited Class A | -4.87% | 18.46% | -34.85% | -96.25% | -96.25% |
Idexx Laboratories, Inc. | 3.06% | -6.93% | 12.31% | -21.35% | 77.73% |
Agilent Technologies Inc. | 4.47% | 0.3% | 30.99% | -5.54% | 92.48% |
Thermo Fisher Scientific, Inc. | -0.98% | 3.7% | 20.66% | 5.08% | 107.82% |
Danaher Corp. | 2.19% | 10.74% | 24.74% | -9.68% | 93.67% |
Iqvia Holdings Inc. | -8.36% | -5.82% | 14.95% | -5.0% | 52.93% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Prenetics Global Limited Class A | 1.03 | NA | 0.0 | -3.32 | -0.24 | -0.11 | NA | 16.33 |
Idexx Laboratories, Inc. | 47.87 | 47.87 | 5.09 | 10.59 | 0.63 | 0.23 | NA | 19.16 |
Agilent Technologies Inc. | 30.05 | 30.05 | 3.16 | 5.24 | 0.25 | 0.08 | 0.01 | 20.53 |
Thermo Fisher Scientific, Inc. | 38.03 | 38.03 | 2.28 | 21.73 | 0.14 | 0.05 | 0.0 | 124.17 |
Danaher Corp. | 50.26 | 50.26 | 2.71 | 7.59 | 0.08 | 0.04 | 0.0 | 68.92 |
Iqvia Holdings Inc. | 29.57 | 29.57 | 1.15 | 11.2 | 0.23 | 0.05 | NA | 36.83 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Prenetics Global Limited Class A | Buy | $50.6M | -96.25% | 1.03 | -262.11% |
Idexx Laboratories, Inc. | Buy | $40.0B | 77.73% | 47.87 | 22.34% |
Agilent Technologies Inc. | Buy | $42.1B | 92.48% | 30.05 | 21.75% |
Thermo Fisher Scientific, Inc. | Buy | $234.1B | 107.82% | 38.03 | 14.69% |
Danaher Corp. | Buy | $197.8B | 93.67% | 50.26 | 17.83% |
Iqvia Holdings Inc. | Buy | $41.5B | 52.93% | 29.57 | 9.39% |
Insights on Prenetics Global Limited Class A
Revenue is up for the last 3 quarters, 4.86M → 6.41M (in $), with an average increase of 12.9% per quarter
Netprofit is up for the last 2 quarters, -19.04M → -8.56M (in $), with an average increase of 122.3% per quarter
In the last 1 year, Agilent Technologies Inc. has given 31.0% return, outperforming this stock by 65.8%
Prudential Corp PLC
Aspex Management (HK) Ltd
Nomura Holdings Inc
UBS Group AG
Organization | Prenetics Global Limited Class A |
Employees | 320 |
CEO | Mr. Sheng Wu Yeung |
Industry | Healthcare |
Eagle Pharmaceuticals Inc.
$4.94
+14.88%
Bluebird Bio, Inc.
$4.94
+14.88%
Lantern Pharma Inc
$4.94
+14.88%
Enhabit Inc
$4.94
+14.88%
Iradimed Corp
$4.94
+14.88%
Seres Therapeutics Inc
$4.94
+14.88%
Kiniksa Pharmaceuticals International Plc
$4.94
+14.88%
Airsculpt Technologies
$4.94
+14.88%
Ani Pharmaceuticals Inc
$4.94
+14.88%